Page last updated: 2024-12-07

coronafacic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

coronafacic acid: a polyketide that is coupled to coronamic acid by coronafacate ligase to form coronatine; structure given in first source; RN refers to (3aS-(3aalpha,6beta,7aalpha))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID114969
CHEBI ID80089
MeSH IDM0223958

Synonyms (19)

Synonym
coronafacic acid
62251-98-3
(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroindene-4-carboxylic acid
1h-indene-4-carboxylic acid, 6-ethyl-2,3,3a,6,7,7a-hexahydro-1-oxo-, (3as,6r,7as)-
1h-indene-4-carboxylic acid, 6-ethyl-2,3,3a,6,7,7a-hexahydro-1-oxo-, (3as-(3alpha,6beta,7aalpha))-
6-ethyl-2,3,3as,6r,7,7as-hexahydro-1-oxo-1h-indene-4-carboxylic acid
CHEBI:80089
AKOS026743250
(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydro-1h-indene-4-carboxylic acid
Q27149241
DTXSID80977827
(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydro-1h-indene-4-carboxylicacid
CS-0168710
rel-(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydro-1h-indene-4-carboxylic acid
CS-0168706
EN300-152203
rel-(3ar,6s,7ar)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydro-1h-indene-4-carboxylic acid
66322-23-4
EN300-1588500

Research Excerpts

Effects

ExcerptReferenceRelevance
"Coronafacic acid has been synthesized from a hydrindanone prepared by the cyclization reaction of the enone-aldehyde with samarium (II) iodide."( [6-endo-trig mode cyclization to a hydrindanone using samarium (II) iodide].
Sono, M, 2003
)
1.04
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ketoneA compound in which a carbonyl group is bonded to two carbon atoms: R2C=O (neither R may be H).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (31.82)18.2507
2000's6 (27.27)29.6817
2010's9 (40.91)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.71 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]